Multimorbidity Polypharmacy
Conditions
Interventions
Group 1: Physicians who are part of the cooperating physicians network (RGL) will be enrolled in the project by the project-partners within this network. These doctors in turn enrol patients with at l
Sponsors
IMVR - Institut für Medizinsoziologie, Versorgungsforschung und Rehabilitationswissenschaft der Humanwissenschaftlichen Fakultät und der Medizinischen Fakultät
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: at least 3 chronical conditions.
Exclusion criteria
Exclusion criteria: less then 3 chronical conditions. Excluding Cancer and psychical disorders.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The overall objective of this study is to evaluate the MamBo project in terms of implementation process and effectiveness. The goal of the formative evaluation is to identify the factors that support and inhibit the implementation. The aim of the summative evaluation is to examine whether the care model is superior to regular care. Effectiveness and implementability are examined. When and how: continuous postal surveys of patients, doctors and practice staff, annual focus groups with MoniKas and doctors and interviews with care management and demand management. | — |
Secondary
| Measure | Time frame |
|---|---|
| Relief for doctors and reduction of the costs of care for multimorbid patients (efficiency). When and how: (A)continuous postal survey of physicians (B)Analysis of secondary health insurance data (claim data) at the end of the intervention: A cohort study will be conducted, in which multimorbid patients participating in MamBo as intervention group will be compared with multimorbid patients not participating in MamBo (control group). The comparison populations will be formed according to the Propensity Score Matching (PSM) method from data of the cooperating insurance company. | — |
Countries
Germany
Contacts
Public ContactNicole Balke
Regionales Gesundheitsnetz Leverkusen eG
Outcome results
None listed